arginine vasopressin has been researched along with ADPKD in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Daniel, EA; Fields, TA; Khanna, A; Parnell, SC; Raman, A; Reif, GA; Vivian, JL; Wallace, DP; Zhang, Y | 1 |
| Dzien, A; Eder, S; Hofer, B; Kerschbaum, J; Leierer, J; Mayer, G; Perco, P; Rudnicki, M | 1 |
| Horie, S; Kawano, H; Lu, Y; Muto, S; Nakajima, A | 1 |
| Amaral, AG; Cebotaru, L; de Lemos Barbosa, CM; Guggino, WB; Morales, MM; Onuchic, LF; Souza-Menezes, J | 1 |
| Amro, OW; Noubary, F; Paulus, JK; Perrone, RD | 1 |
| Bankir, L; Grantham, JJ; Torres, VE | 1 |
| Barash, I; Goldfarb, DS; Ponda, MP; Skolnik, EY | 1 |
| Nivens, E; Pinto, CS; Reif, GA; Wallace, DP; White, C | 1 |
| Boertien, WE; Bost, JE; Flessner, MF; Gansevoort, RT; Li, J; Meijer, E; Struck, J; Torres, VE | 1 |
| Belibi, FA; Grantham, JJ; Helmkamp, GM; Li, H; Olsen, L; Reif, G; Wallace, DP; Yamaguchi, T | 1 |
| Grantham, JJ | 1 |
| Torres, VE | 1 |
2 review(s) available for arginine vasopressin and ADPKD
| Article | Year |
|---|---|
A case for water in the treatment of polycystic kidney disease.
Topics: Animals; Arginine Vasopressin; Drinking; Fluid Therapy; Humans; Polycystic Kidney, Autosomal Dominant; Water; Water-Electrolyte Balance | 2009 |
Role of vasopressin antagonists.
Topics: Adolescent; Adult; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Fluids; Cell Proliferation; Drug Evaluation, Preclinical; Hormone Antagonists; Humans; Kidney; Male; Polycystic Kidney, Autosomal Dominant; Receptors, Vasopressin; Tolvaptan; Treatment Outcome | 2008 |
2 trial(s) available for arginine vasopressin and ADPKD
| Article | Year |
|---|---|
Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial.
Topics: Adolescent; Adult; Arginine Vasopressin; Drinking; Female; Humans; Male; Middle Aged; Osmolar Concentration; Pilot Projects; Polycystic Kidney, Autosomal Dominant; Young Adult | 2016 |
A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease.
Topics: Adult; Arginine Vasopressin; Biomarkers; Cyclic AMP; Disease Progression; Down-Regulation; Drinking; Female; Fluid Therapy; Humans; Male; Osmolar Concentration; Pilot Projects; Polycystic Kidney, Autosomal Dominant; Time Factors; Treatment Outcome; Water-Electrolyte Balance | 2010 |
8 other study(ies) available for arginine vasopressin and ADPKD
| Article | Year |
|---|---|
Expression of active B-Raf proto-oncogene in kidney collecting ducts induces cyst formation in normal mice and accelerates cyst growth in mice with polycystic kidney disease.
Topics: Animals; Arginine Vasopressin; Cyclic AMP; Cysts; Fibrosis; Kidney Tubules, Collecting; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Polycystic Kidney, Autosomal Dominant; Polycystic Kidney, Autosomal Recessive; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins B-raf; Proto-Oncogenes; Receptors, Cell Surface | 2022 |
Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease.
Topics: Adult; Aged; Aged, 80 and over; Angiotensinogen; Apelin; Arginine Vasopressin; Biomarkers; Epidermal Growth Factor; Female; Humans; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Vascular Endothelial Growth Factor A | 2021 |
Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
Topics: Adult; Aged; Arginine Vasopressin; Biomarkers; Body Mass Index; Cyclic AMP; Disease Progression; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Kidney; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Insufficiency, Chronic; Reproducibility of Results | 2015 |
Regulation of CFTR Expression and Arginine Vasopressin Activity Are Dependent on Polycystin-1 in Kidney-Derived Cells.
Topics: Animals; Antidiuretic Agents; Arginine Vasopressin; Cell Line; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Gene Expression Regulation; Kidney; Mice; Mice, Inbred CFTR; Polycystic Kidney, Autosomal Dominant; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transfection; TRPP Cation Channels | 2016 |
Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells.
Topics: Adenylyl Cyclases; Aquaporin 2; Arginine Vasopressin; Calmodulin; Cell Proliferation; Cells, Cultured; Chlorides; Cyclic AMP; Down-Regulation; Epithelial Cells; Humans; Kidney; Polycystic Kidney, Autosomal Dominant; Receptors, Vasopressin; Signal Transduction; Sulfonamides | 2012 |
Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort.
Topics: Adult; Arginine Vasopressin; Biomarkers; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Kidney; Longitudinal Studies; Male; Organ Size; Polycystic Kidney, Autosomal Dominant; Young Adult | 2013 |
Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
Topics: Adrenergic Agonists; Adult; Arginine Vasopressin; Cell Division; Cells, Cultured; Cyclic AMP; Cyst Fluid; Deamino Arginine Vasopressin; Dinoprostone; Epinephrine; Epithelial Cells; Humans; Infant; Kidney; Parathyroid Hormone; Polycystic Kidney, Autosomal Dominant; Renal Agents | 2004 |
Therapy for polycystic kidney disease? It's water, stupid!
Topics: Arginine Vasopressin; Humans; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Polycystic Kidney, Autosomal Recessive; Vasopressins | 2008 |